Global Anticoagulants Market Size & Outlook, 2023-2030
Global anticoagulants market, 2018-2030 (US$M)
Related Markets
Global anticoagulants market highlights
- The global anticoagulants market generated a revenue of USD 34,801.7 million in 2023 and is expected to reach USD 60,433.8 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 8.2% by 2030.
- In terms of segment, novel oral anticoagulants (noacs) accounted for a revenue of USD 19,929.2 million in 2023.
- Heparin and Low Molecular Weight Heparin (LMWH) is the most lucrative drug category segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, Kuwait is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 34,801.7 million |
| Market revenue in 2030 | USD 60,433.8 million |
| Growth rate | 8.2% (CAGR from 2023 to 2030) |
| Largest segment | Novel oral anticoagulants (noacs) |
| Fastest growing segment | Heparin and Low Molecular Weight Heparin (LMWH) |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Novel Oral Anticoagulants (NOACs), Vitamin K Antagonist, Direct Thrombin Inhibitors, Heparin and Low Molecular Weight Heparin (LMWH) |
Other key industry trends
- In terms of revenue, the North America accounted for 50.8% of the global anticoagulants market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Kuwait is the fastest growing regional market and is projected to reach USD 70.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Anticoagulants Market Scope
Anticoagulants Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global anticoagulants market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anticoagulants market will help companies and investors design strategic landscapes.
Novel oral anticoagulants (noacs) was the largest segment with a revenue share of 57.27% in 2023. Horizon Databook has segmented the Global anticoagulants market based on novel oral anticoagulants (noacs), vitamin k antagonist, direct thrombin inhibitors, heparin and low molecular weight heparin (lmwh) covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Anticoagulants Drug Category Outlook (Revenue, USD Million, 2018-2030)
- Novel Oral Anticoagulants (NOACs)
- Eliquis
- Xarelto
- Savaysa & lixiana
- Pradaxa
- Vitamin K Antagonist
- Direct Thrombin Inhibitors
- Heparin and Low Molecular Weight Heparin (LMWH)
- Others
- Novel Oral Anticoagulants (NOACs)
- Global Anticoagulants Route of Administration Outlook (Revenue, USD Million, 2018-2030)
- Oral Anticogulants
- Injectable Anticogulants
- Global Anticoagulants Application Outlook (Revenue, USD Million, 2018-2030)
- Atrial Fibrillation/Myocardial Infarction (Heart Attack)
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism
- Other Applications
Reasons to subscribe to Global anticoagulants market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global anticoagulants market databook
-
Our clientele includes a mix of anticoagulants market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global anticoagulants market , including forecasts for subscribers. This global databook contains high-level insights into Global anticoagulants market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global anticoagulants market size, by region, 2018-2030 (US$M)
Top 10 countries: Anticoagulants market size, 2023 (US$M)
Global anticoagulants market share, by drug category, 2023 & 2030 (%, US$M)
Anticoagulants market: Opportunity assessment by country
Global anticoagulants market, by region, 2023 (US$M)
| Drug Category | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 12,547.3 | 14,242.3 | 15,431.2 | 16,581.3 | 17,052.5 | 17,666.9 | 18,491.4 | 19,551.1 | 20,879.5 | 22,520.2 | 24,529.5 | 26,978.9 | 29,959.8 | 7.8% |
| Europe | 7,498.7 | 8,537.2 | 9,277.4 | 9,998.8 | 10,313.9 | 10,717.9 | 11,252.1 | 11,933.1 | 12,782.9 | 13,829.7 | 15,110.0 | 16,670.1 | 18,569.5 | 8.2% |
| Asia Pacific | 3,225.4 | 3,728.6 | 4,113.4 | 4,499.6 | 4,709.8 | 4,965.5 | 5,287.8 | 5,687.2 | 6,177.2 | 6,775.2 | 7,503.1 | 8,389.0 | 9,468.7 | 9.7% |
| Latin America | 606.8 | 693.8 | 757.2 | 819.6 | 849.0 | 886.0 | 934.1 | 994.9 | 1,070.2 | 1,162.8 | 1,275.7 | 1,413.3 | 1,580.9 | 8.6% |
| MEA | 431.4 | 483.0 | 516.0 | 546.6 | 554.0 | 565.4 | 582.8 | 606.6 | 637.6 | 676.5 | 724.7 | 783.5 | 854.9 | 6.1% |
| Overall | 24,309.5 | 27,684.8 | 30,095.2 | 32,445.8 | 33,479.2 | 34,801.7 | 36,548.2 | 38,772.9 | 41,547.5 | 44,964.4 | 49,142.9 | 54,234.8 | 60,433.8 | 8.2% |
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
